Editas Medicine, Inc. (EDIT): Price and Financial Metrics

Editas Medicine, Inc. (EDIT): $2.41

0.07 (-2.82%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

C

Add EDIT to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#189 of 332

in industry

EDIT Price/Volume Stats

Current price $2.41 52-week high $11.69
Prev. close $2.48 52-week low $2.35
Day low $2.35 Volume 2,817,500
Day high $2.47 Avg. volume 1,937,624
50-day MA $3.26 Dividend yield N/A
200-day MA $5.24 Market Cap 198.94M

EDIT Stock Price Chart Interactive Chart >


Editas Medicine, Inc. (EDIT) Company Bio


Editas Medicine Inc. operates as a genome editing company. It focuses on translating its genome editing technology into a class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a range of diseases at the genetic level. Editas Medicine Inc. was formerly known as Gengine, Inc. and changed its name to Editas Medicine Inc. in November 2013. The company was founded in 2013 and is based in Cambridge, Massachusetts.


EDIT Latest News Stream


Event/Time News Detail
Loading, please wait...

EDIT Latest Social Stream


Loading social stream, please wait...

View Full EDIT Social Stream

EDIT Price Returns

1-mo -26.75%
3-mo -37.73%
6-mo -57.19%
1-year -77.03%
3-year -92.88%
5-year -90.11%
YTD -76.21%
2023 14.21%
2022 -66.59%
2021 -62.13%
2020 136.78%
2019 30.15%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!